Prescribing antibiotics in odontology and stomatology;Prescription des antibiotiques en odontologie et stomatologie

Medecine et Maladies Infectieuses

Volumn 32, Issue 3, 2002, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROIMIDAZOLE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ARTHRISONE; ATRIDOX; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CORTEXAN FRAMYCETINE; CYCLINE; DOXYCYCLINE; FLEXICONES; FRAMYCETIN; GENTAMICIN; GLYCOPEPTIDE; GRINAZOLE; IMIPRAMINE; LINCOSAMIDE; MACROLIDE; MESTACINE; METROCOL; METROGENE; METRONIDAZOLE; MINOCYCLINE; NEOCONES; NEOMYCIN; PAROCLYNE; PENICILLIN G; POLYMYXIN B; PRISTINAMYCIN; PULPOMIXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEPTOMIXINE; SPIRAMYCIN; STREPTOGRAMIN; TEICOPLANIN; TETRACYCLINE; TYROTHRICIN; VANCOMYCIN;

ADJUVANT THERAPY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; CELLULITIS; DENTAL CARIES; DRUG ABSORPTION; DRUG CHOICE; DRUG DIFFUSION; DRUG INDICATION; DRUG TOLERANCE; DRUG TRANSFORMATION; DRUG UTILIZATION; HUMAN; IATROGENIC DISEASE; INFECTION RISK; LAVAGE; ODONTOLOGY; PATHOLOGY; PRESCRIPTION; REVIEW; STOMATOLOGY; TOOTH INFECTION;

EID: 0036123428     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (259)

1. Prescription d'antibiotiques en odontologie et stomatologie
2. Trends in antimicrobial drug use in the community between 1981 and 1992 in France
3. Sore throat management in general practice
4. Reactions typically shared by more than one class of beta lactam antibiotics
5. Do antimicrobials increase the rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
6. Trends in antibiotic resistance of respiratory pathogens: An analysis and commentary on a collaborative surveillance study
7. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians
8. Epidemiology of penicillin resistant pneumococci (PRP) in Iceland. Hope for the future?
9. The effects of changes in the consumption of macrolides antibiotics on erythromycin resistance in group A streptococci in Finland
10. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria
11. Un exemple de résistance liée à la pression de sélection en ville: Le pneumocoque
12. Antibiotiques, généralités
13. Recommandations pour la pratique de l'antibioprophylaxie en chirurgie
14. Prescription pluri-médicamenteuse chez la personne âgée de plus de 70 ans
15. Development of oral bacterial flora in young children
16. Microbiology of apical periodontitis
17. Interprétation des résultats bactériologiques en parodontie
18. Bactériologie buccale
19. Les parodontites. Table ronde
20. Les Bacteroides de la cavité buccale. Pathogénicité et facteurs de virulence
21. Anaérobies et pathologie bucco-dentaire
22. Nomenclature for aerobic and facultative bacteria
23. Microbiology terminology update: Clinically significant anaerobic gram-positive and gram-negative bacteria (excluding spirochetes)
24. La pénicilline en stomatologie
25. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
26. Prophylaxie de l'endocardite infectieuse
27. Prevention of infective endocarditis associated with dental treatment and other medical interventions
28. A practical guide to antibiotic prophylaxis in restorative dentistry
29. Endocardites infectieuses et antibioprophylaxie lors de traitements dentaires
30. Antibiotic prophylaxis in dentistry: A review and practice recommendations
31. Antibiotic prophylaxis for dental patients with total joint replacements
32. Etude de la flore sous-gingivale des implants ostéo-intégrés dans des situations d'échecs et de succés chez des patients édentés et partiellement édentés
33. Endodontics in the adult patient: The role of antibiotics
34. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis
35. A 15-month evaluation of the effects of repeated subgingival minocycline in chronic adult periodontitis
36. A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets
37. A controlled multicenter study of adjunctive use of tetracycline periodontal fibers in mandibular class II furcations with persistent bleeding
38. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results
39. Irrigation with antimicrobial agents for the treatment of periodontitis - Is it effective?
40. Cellulites cervicales diffuses à propos de 15 cas
41. Cellulites faciales graves diffuses
42. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study
43. Infective endocarditis and dentistry: Outcome-based research
44. Dental treatment and bacterial endocarditis
45. Oral amoxicillin as prophylaxis for endocarditis: What is the optimal dose?
46. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci
47. Comparison of the efficacy, safety and tolerability of azithromycin and co-amoxiclav in the treatment of acute periapical abscesses
48. Routine prophylactic antibiotic use in diabetic dental patients
49. Antibiotic prescribing for dental conditions: General medical practitioners and dentists compared
50. Development of a classification system for periodontal diseases and conditions
51. Comparison of the clinical effects of subgingival application of metronidazole 25% gel and scaling in the treatment of adult periodontitis
52. Cellulites cervicales diffuses à propos de 15 cas
53. Endodontie et endocardite infectieuse
54. Experimentally induced peri-implantitis: A review of different treatment methods described in the literature
55. Actinomycotic osteomyelitis of the mandible: Review of 15 cases
56. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial
57. Clinical and microbial considerations for the treatment of an extended kindred with seven cases of prepubertal periodontitis: A 2-year follow-up
58. The use of systemic antibiotics in dental practice
59. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases
60. Clinical evaluation of tetracycline HCl conditioning in the treatment of gingival recessions. A comparative study
61. Microbiology of periapical abscesses and associated maxillary sinusitis
62. Actinobacillus actinomycetemcomitans in destructive periodontal disease. Three-year follow-up results
63. Tetracycline fiber used alone or with scaling and root planing in periodontal maintenance patients: Clinical results
64. Site specific delivery of antimicrobial agents for periodontal disease
65. Medications as risk factors for periodontal disease
66. The general practitioner's perspective of the etiology, prevention, and treatment of dry socket
67. Clinical and microbiological features of refractory periodontitis subjects
68. ABC of oral health. Periodontal disease
69. Treatment of periodontal disease based on microbiological diagnosis. A 5-year follow-up on individual patterns
70. The prophylaxis of infective endocarditis: Current practices in France. French Federation of Cardiology
71. Etude comparative clarithromycine contre l'association métronidazole-spiramycine dans les infections dentaires
72. Dental considerations for the patient with renal disease receiving hemodialysis
73. Prophylactic use of antibiotics for procedures after total joint replacement
74. Oral management of the patient with end-stage liver disease and the liver transplant patient
75. A new causal model of dental diseases associated with endocarditis
76. The use of locally delivered doxycycline in the treatment of periodontitis. Clinical results
77. Bacterial endocarditis: Results of a survey in a children's hospital in France
78. Antibiotics for the prevention of endocarditis during dentistry: Time to scale back?
79. Antimicrobial treatment of periodontal diseases disturbs the human ecology: A review
80. Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis
81. Evidence versus empiricism: Rational use of systemic antimicrobial agents for treatment of periodontitis
82. Topical tetracycline: Potential for allergic reaction or bacterial resistance
83. Infective endocarditis: Dental implications and new guidelines for antibiotic prophylaxis
84. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: A review of the literature
85. Systemic doxycycline administration in the treatment of periodontal infections (I). Effect on the subgingival microbiota
86. Systemic doxycycline administration in the treatment of periodontal infections (II). Effect on antibiotic resistance of subgingival species
87. Dental management of people with renal disease and renal transplants
88. Clinical use of antibiotics in dental practice
89. Adjunctive controlled topical application of tetracycline HCl in the treatment of localized persistent or recurrent periodontitis. Effects on clinical parameters and elastase-alphal-proteinase inhibitor in gingival crevicular fluid
90. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis
91. Differential effects of systemic metronidazole and amoxicillin on Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in intraoral habitats
92. Penicillin as a supplement in resolving the localized acute apical abscess
93. Ostéite circonscrite mandibulaire de l'enfant par vole hématogène
94. Dental disease, caries related microflora and salivary IgA of children with severe congenital cardiac disease: An epidemiological and oral microbial survey
95. Recognition and treatment of rapidly progressive periodontitis
96. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months
97. Consensus report. Periodontal diseases: Pathogenesis and microbial factors
98. Periodontal diseases: Pathogenesis and microbial factors
99. Prevention of bacterial endocarditis
100. Microbiology of recurrent parotitis
101. Periapical abscesses: Causal bacteria and antibiotic sensitivity
102. A randomized controlled trial of a 2% minocycline gel as an adjunct to nonsurgical periodontal treatment, using a design with multiple matching criteria
103. Antibiotics in endodontics: Therapeutic considerations
104. Locally delivered antimicrobials in periodontal therapy
105. Conceptualization vs reality in the treatment of periodontal diseases
106. The role of local drug delivery in the management of periodontal diseases: A comprehensive review
107. The role of tetracycline-impregnated fibers in retreatment
108. The role of controlled drug delivery for periodontitis
109. A review of localized juvenile periodontitis (LJP): II. Clinical trials and treatment guidelines
110. Treatment of periodontitis in the diabetic patient. A critical review
111. Dental implant installation without antibiotic prophylaxis
112. Antimicrobial resistance: Dentistry's role
113. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction
114. Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis
115. Adverse drug interactions in dental practice: Interactions involving antibiotics. Part II of a series
116. Systemic antibiotics in periodontal therapy. Friend or foe?
117. Principles and practice of antibiotic therapy
118. Orthodontics and infective endocarditis
119. Chemical treatment of periodontitis: Local delivery of antimicrobials
120. A new horizon for the dental hygienist: Controlled local delivery of antimicrobials
121. Controlled local delivery of antimicrobials in the treatment of periodontitis
122. Antibiotic susceptibility of putative periodontal pathogens in advanced periodontitis patients
123. Oral colonization by anaerobic bacteria during childhood: Role in health and disease
124. Refractory periodontitis: Critical questions in clinical management
125. Past administration of β-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections
126. Incidence of β-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections
127. Procedures associated with infective endocarditis in adults. A case control study
128. Clinical trials on therapies for peri-implant infections
129. Infections associated with dental procedures in total hip arthroplasty
130. Development of resistance to metronidazole and minocycline in vitro
131. Considerations in the management of maxillofacial infections in the pregnant patient
132. Evaluation of root canal bacteria and their antimicrobial susceptibility in teeth with necrotic pulp
133. Prévention de l'endocardite infectieuse
134. Pre- and post-implantation microbiota of the tongue, teeth, and newly-placed implants
135. Microbial findings at failing implants
136. Antibiotic prophylaxis for infective endocarditis
137. Brain abscesses caused by oral infection
138. Effects of topical metronidazole and tetracycline in treatment of adult periodontitis
139. Patients with prosthetic joints: Are they at risk when receiving invasive dental procedures?
140. Oral microflora as a cause of endocarditis and other distant site infections
141. Nonsurgical treatment of patients with periodontal disease
142. The antimicrobial treatment of periodontal disease: Changing the treatment paradigm
143. Repeated metronidazole and amoxicillin treatment of periodontitis. A follow-up study
144. Effects of metronidazole plus amoxicillin in progressive untreated adult periodontitis: Results of a single 1-week course after 2 and 4 months
145. Odontogenic bacteremia following tooth cleaning procedures in children
146. Local delivery of antimicrobial agents for the treatment of periodontitis
147. Current concepts in diagnosis and treatment of periodontitis
148. Refractory periodontitis or recurrence of disease
149. Effets des antibiotiques à libération contrôlée dans le traitement des parodontites
150. Periodontal tissue disposition of azithromycin
151. Clindamycin alone compared with clindamycin plus ibuprofen for odontogenic infections
152. Pharmacologic management of periodontal diseases using systemically administered agents
153. Early management of dental pain in children and adolescents
154. Prophylaxie de l'endocardite bactérienne et soins dentaires
155. A clinical evaluation of demineralized freeze-dried bone allograft in combination with tetracycline in the treatment of periodontal osseous defects
156. Acute viral and bacterial infections of the salivary glands
157. Periodontal implications: Medically compromised patients
158. Antibiotic resistance and maxillofacial pathogens: Emerging treatment issues
159. Systemic antimicrobial treatment and guided tissue regeneration. Clinical and microbiological effects in furcation defects
160. Antibiotic therapy in impacted third molar surgery
161. Dental therapeutic indications for the newer long-acting macrolide antibiotics
162. Selecting drugs for the pregnant dental patient
163. Adverse drug interactions in dental practice. Professional and educational implications
164. Le plan de traitement paro-implanto-prothétique. Préparations parodontales et temps chirurgicaux implantaires
165. Perioperative antibiotic prophylaxis in maxillofacial surgery: Penetration of clindamycin into various tissues
166. Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis
167. Periodontal pocket irrigation as adjunctive treatment
168. Design and implementation of clinical trials of antimicrobial drugs and devices used in periodontal disease treatment
169. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis
170. Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis
171. Antibiotic susceptibility of bacteria detected from the root canal exudate of persistent apical periodontitis
172. Pharmacokinetic principles of antimicrobial therapy
173. Macrolide antibiotics
174. Antibiotic prophylaxis: The clinical significance of its recent evolution
175. The 1997 prevention of bacterial endocarditis recommendations by the American Heart Association: Questions and answers
176. A double-blind trial of tetracycline in the management of early onset periodontitis
177. A study of therapeutic antibiotic prescribing in National Health Service general dental pratice in England
178. A study of prophylactic antibiotic prescribing in National Health Service general dental pratice in England
179. Cases of HIV-associated characteristic periodontal diseases
180. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management
181. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease
182. Etude in vitro de la sensibilité aux antibiotiques des bactéries anaerobies strictes associées à la maladie parodontale
183. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets
184. Les complications loco-regionales et generales des foyers infectieux dentaires
185. Local delivery of antimicrobial agents in the periodontal pocket
186. Treatment of periodontal disease based on microbiological diagnosis. Relation between microbiological and clinical parameters during 5 years
187. Dentists are innocent: "Everyday" bacteremia is the real culprit: A review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children
188. Bacteremia of dental origin and antimicrobial sensitivity following oral surgical procedures in children
189. Bacteriaemia following local anasthetic injections in children
190. Intensity of bacteraemia associated with conservative dental procedures in children
191. Bacterial endocarditis and orthodontics
192. Clinical consideration for infective endocarditis antibiotic prophylaxis
193. Coronary artery stents: Review and patient-management recommandations
194. Antibiotic resistance in oral/respiratory bacteria
195. In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odomogenic abscesses
196. Endocarditis prophylaxis
197. Prosthetic joints, dental treatment, and anitibiotic prophylaxis
198. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva
199. Antimicrobial treatment options in the management of odontogenic infections
200. Epidemiologic review of pediatric and adult maxillofacial infections in hospitalized patients
201. Macrolides and changes in the oral flora
202. Azithromycin in the treatment of periodontal disease. Effect on microbial flora
203. Repopulation of periodontal pockets by microbial pathogens in the absence of supportive therapy
204. Systemic antibiotics in periodontics
205. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: Occurrence and treatment
206. An update on antimicrobial chemotherapy: 1. The mechanisms of action of antibiotics
207. An update on antimicrobial chemotherapy: 3. Antimicrobial resistance and the oral cavity
208. Prevention des endocardites bactériennes. D'après les nouvelles recommendations de l'American Heart Association
209. Subgingival delivery of therapeutic agents in the treatment of periodontal diseases
210. Ostéoradionécrose mandibulaire et antibiothérapie
211. Clinical and antimicrobial effects of a single episode of subgingival irrigation with tetracycline HCl or chlorhexidine in deep periodontal pockets
212. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum
213. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid
214. Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial
215. Local delivery of tetracycline: From concept to clinical application
216. Clinical effect of subgingival tetracycline irrigation and tetracycline-loaded fiber application in the treatment of adult periodontitis
217. Treatment of chronic suppurative osteomyelitis of the mandible
218. Systemic antibiotic therapy in periodontics
219. Systemic antibiotic therapy in severe periodontitis
220. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain
221. The use of locally delivered minocycline in the treatment of chronic periodontitis. A review of the literature
222. The effect of postsurgical antibiotics and a bioabsorbable membrane on regenerative healing in Class II furcation defects
223. Dental extraction wound management: Medicating postextraction sockets
224. The acquisition of antibiotic resistance in the periodontal microflora
225. A review of common dental treatments during pregnancy: Implications for patients and dental personnel
226. Periodontitis for medical practitioners
227. Tetracycline and its analogues: A therapeutic paradigm in periodontal diseases
228. Prophylactic antibiotic therapy prior dental treatment fir patients with end-stage renal disease
229. The impact of new technologies to diagnose and treat periodontal disease. A look to the future
230. Tetracycline fibers plus scaling and root planing versus scaling and root planing alone: Similar results after 5 years
231. Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy
232. Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study
233. Microbiological response of localized sites with recurrent periodontitis in maintenance patients treated with tetracycline fibers
234. Clinical response of localized recurrent periodontitis treated with scaling, root planing, and tetracycline fiber
235. Periodontal disease and risk of cerebrovascular disease. The first national health examination survey and its follow-up study
236. Guidelines for antibiotic prophylaxis for dental patients with joint replacements
237. Recent report calling for reduction of antibiotic prophylaxis in dental procedures: A response
238. Evaluation of adjunctive tetracycline fiber therapy with scaling and root planing: Short-term clinical results
239. A clinical and microbiological evaluation of systemic and local metronidazole delivery in early onset periodontitis patients
240. Fatal Staphylococcus aureus infective endocarditis. The dental implications
241. Tetracycline-coated polytetrafluoroethylene barrier membranes in the treatment of intraosseous periodontal lesions
242. Preoperative antibiotic prophylaxis in orthognatihic surgery: A randomized, double-blind, and placebo-controlled clinical study
243. New pathogens in neutropenic patients with cancer: An update for the new millenium
244. Topical and systemic antimicrobial therapy in guided tissue regeneration